Pooled RCT evidence from three EU consortia shows non-nutritive sweeteners may support weight loss maintenance without adverse effects on biomarkers or taste preference.
Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.
Live from the Future Nutra Innovation Summit, Cassie Evans, PhD, RD, explains what sets Helaina's effera human-identical lactoferrin apart in multiple aspects.
The randomized, double-blind placebo-controlled study found laboratory safety markers remained within normal ranges across treatment and placebo groups.
A 28-day evaluation of TriNutra’s 5% B'utyQuin scalp lotion reported reduced hair loss and modest density increases in 22 adults, adding early clinical data to a cosmetic ingredient formulators are positioning for scalp health claims.
Why do promising nutraceutical ingredients underperform in human trials? This piece explores how phenotype-based recruitment aligns participant biology with mechanism, reducing signal dilution and producing more commercially meaningful efficacy evidence.
The panel closes by discussing which ingredient pairings show real biological synergy, whether brands are thinking about nutrient absorption competition, and why the budget-conscious end of the market may be the industry's most overlooked opportunity.